OMB
APPROVAL
|
|
OMB
NUMBER:
|
|
Expires:
|
February
28, 2009
|
Estimated
average burden
|
|
hours
per
response...............14.5
|
CUSIP
No. 29264F205
|
||||
1
|
Name
of Reporting Person.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
D.E.
Shaw Shaw Composite Portfolios, L.L.C.
FEIN
13-4152438
|
|||
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|||
3
|
SEC
Use Only
|
|||
4
|
Source
of Funds (See Instructions)
WC
|
|||
5
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||
o | ||||
6
|
Citizenship
or Place of Organization
Delaware
|
|||
Number
of
Shares
Beneficially
|
7
|
Sole
Voting Power
-0-
|
||
Owned
by
Each
Reporting
|
8
|
Shared
Voting Power
4,388,158
|
||
Person
With
|
9
|
Sole
Dispositive Power
-0-
|
||
10
|
Shared
Dispositive Power
4,388,158
|
|||
11
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
4,388,158
|
|||
12
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||
o | ||||
13
|
Percent
of Class Represented by Amount in Row (11)
3.3%
|
|||
14
|
Type
of Reporting Person (See Instructions)
OO
|
CUSIP
No. 29264F205
|
||||
1
|
Name
of Reporting Person.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
D.E.
Shaw Valence Portfolios, L.L.C.
FEIN
13-4046559
|
|||
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|||
3
|
SEC
Use Only
|
|||
4
|
Source
of Funds (See Instructions)
WC
|
|||
5
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||
o | ||||
6
|
Citizenship
or Place of Organization
Delaware
|
|||
Number
of
Shares
Beneficially
|
7
|
Sole
Voting Power
-0-
|
||
Owned
by
Each
Reporting
|
8
|
Shared
Voting Power
2,999,800
|
||
Person
With
|
9
|
Sole
Dispositive Power
-0-
|
||
10
|
Shared
Dispositive Power
2,999,800
|
|||
11
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
2,999,8001
|
|||
12
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||
o | ||||
13
|
Percent
of Class Represented by Amount in Row (11)
2.2%
|
|||
14
|
Type
of Reporting Person (See Instructions)
OO
|
CUSIP
No. 29264F205
|
||||
1
|
Name
of Reporting Person.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
D.E.
Shaw Synoptic Portfolios 2, L.L.C.
FEIN
20-4229475
|
|||
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|||
3
|
SEC
Use Only
|
|||
4
|
Source
of Funds (See Instructions)
WC
|
|||
5
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||
o | ||||
6
|
Citizenship
or Place of Organization
Delaware
|
|||
Number
of
Shares
Beneficially
|
7
|
Sole
Voting Power
-0-
|
||
Owned
by
Each
Reporting
|
8
|
Shared
Voting Power
819
|
||
Person
With
|
9
|
Sole
Dispositive Power
-0-
|
||
10
|
Shared
Dispositive Power
819
|
|||
11
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
819
|
|||
12
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||
o | ||||
13
|
Percent
of Class Represented by Amount in Row (11)
0.0%
|
|||
14
|
Type
of Reporting Person (See Instructions)
OO
|
CUSIP
No. 29264F205
|
||||
1
|
Name
of Reporting Person.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
D.E.
Shaw & Co., L.L.C.
FEIN
13-3799946
|
|||
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|||
3
|
SEC
Use Only
|
|||
4
|
Source
of Funds (See Instructions)
AF
|
|||
5
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||
o | ||||
6
|
Citizenship
or Place of Organization
Delaware
|
|||
Number
of
Shares
Beneficially
|
7
|
Sole
Voting Power
-0-
|
||
Owned
by
Each
Reporting
|
8
|
Shared
Voting Power
4,388,977
|
||
Person
With
|
9
|
Sole
Dispositive Power
-0-
|
||
10
|
Shared
Dispositive Power
4,388,977
|
|||
11
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
4,388,977
|
|||
12
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||
o | ||||
13
|
Percent
of Class Represented by Amount in Row (11)
3.3%
|
|||
14
|
Type
of Reporting Person (See Instructions)
OO
|
CUSIP
No. 29264F205
|
||||
1
|
Name
of Reporting Person.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
D.E.
Shaw & Co., L.P.
FEIN
13-3695715
|
|||
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|||
3
|
SEC
Use Only
|
|||
4
|
Source
of Funds (See Instructions)
AF
|
|||
5
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||
o | ||||
6
|
Citizenship
or Place of Organization
Delaware
|
|||
Number
of
Shares
Beneficially
|
7
|
Sole
Voting Power
-0-
|
||
Owned
by
Each
Reporting
|
8
|
Shared
Voting Power
7,492,210
|
||
Person
With
|
9
|
Sole
Dispositive Power
-0-
|
||
10
|
Shared
Dispositive Power
7,544,410
|
|||
11
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
7,544,410
|
|||
12
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||
o | ||||
13
|
Percent
of Class Represented by Amount in Row (11)
5.6%
|
|||
14
|
Type
of Reporting Person (See Instructions)
IA,
PN
|
CUSIP
No. 29264F205
|
||||
1
|
Name
of Reporting Person.
I.R.S.
IDENTIFICATION NO. OF ABOVE PERSON
David
E. Shaw
|
|||
2
|
Check
the Appropriate Box if a Member of a Group (See Instructions)
|
|||
3
|
SEC
Use Only
|
|||
4
|
Source
of Funds (See Instructions)
AF
|
|||
5
|
Check
if Disclosure of Legal Proceedings Is Required Pursuant to Items
2(d) or
2(e)
|
|||
o | ||||
6
|
Citizenship
or Place of Organization
Delaware
|
|||
Number
of
Shares
Beneficially
|
7
|
Sole
Voting Power
-0-
|
||
Owned
by
Each
Reporting
|
8
|
Shared
Voting Power
7,492,210
|
||
Person
With
|
9
|
Sole
Dispositive Power
-0-
|
||
10
|
Shared
Dispositive Power
7,544,410
|
|||
11
|
Aggregate
Amount Beneficially Owned by Each Reporting Person
7,544,410
|
|||
12
|
Check
if the Aggregate Amount in Row (11) Excludes Certain Shares (See
Instructions)
|
|||
o | ||||
13
|
Percent
of Class Represented by Amount in Row (11)
5.6%
|
|||
14
|
Type
of Reporting Person (See Instructions)
IN
|
Item
1.
|
Security
and Issuer
|
||
This
statement on Schedule 13D relates to the shares of Common Stock,
$0.01 par
value per share (the “Common Shares”) of ENDO Pharmaceuticals Holdings
Inc. (the “Issuer”). The principal executive offices of the
Issuer are located at 100 Endo Blvd, Chadds Ford, PA
19317.
|
|||
Item
2.
|
Identity
and Background
|
||
(a),
(f) This statement is filed on behalf of D. E. Shaw Composite Portfolios,
L.L.C., a Delaware limited liability company (“Composite), D. E. Shaw
Valence Portfolios, L.L.C., a Delaware limited liability company
(“Valence”), D. E. Shaw Synoptic Portfolios 2, L.L.C., a Delaware limited
liability company (“Synoptic”), D. E. Shaw & Co., L.L.C., a Delaware
limited liability company (“DESCO LLC”), D. E. Shaw & Co., L.P., a
Delaware limited partnership (“DESCO LP”), and David E. Shaw, a citizen of
the United States of America (David E. Shaw, together with Composite,
Valence, Synoptic, DESCO LLC, and DESCO LP, collectively, the “Reporting
Persons”). The Reporting Persons are filing jointly, and the
agreement among the Reporting Persons to file jointly is attached
hereto
as Exhibit 3 and incorporated herein by reference.
|
|||
(b)
The business address and principal office, as applicable, of all
Reporting
Persons is 120 West Forty-Fifth Street, 39th Floor, Tower 45, New
York, NY
10036.
|
|||
(c)
The principal business of Composite is that of a limited liability
company
focusing primarily on multiple investment strategies. The
principal business of Valence is that of a limited liability company
focusing primarily on equity and equity-linked securities related
investment strategies. The principal business of Synoptic is
that of a limited liability company focusing primarily on equity-related
investment strategies. None of Composite, Valence, or Synoptic
has any executive officers or directors. The principal business
of DESCO LLC is to act as managing member to certain funds, including,
without limitation, Composite and Synoptic. The principal
business of DESCO LP is to act as an investment adviser to certain
funds,
including, without limitation, Composite, Valence, and
Synoptic. DESCO LP is also the managing member to certain
entities, including, without limitation, Valence and D. E. Shaw Investment
Management, L.L.C. (“DESIM LLC”). D. E. Shaw & Co., Inc., a
Delaware corporation (“DESCO Inc.”), is the general partner of DESCO
LP. D. E. Shaw & Co. II, Inc., a Delaware corporation
(“DESCO II, Inc.”), is the managing member of DESCO LLC. David
E. Shaw is the president and sole shareholder of DESCO Inc. and DESCO
II,
Inc.
|
|||
(d),
(e) During the last five years, neither any Reporting Person nor,
to the
best knowledge of any Reporting Person, any person named in this
Item 2,
has been (i) convicted in a criminal proceeding (excluding traffic
violations or similar misdemeanors) or (ii) a party to a civil proceeding
of a judicial or administrative body of competent jurisdiction and
as a
result of such proceeding was or is subject to a judgment, decree,
or
final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding
any
violations with respect to such laws.
|
|||
Item
3.
|
Source
and Amount of Funds or Other Consideration
|
||
In
acquiring $4,388,158 Common Shares owned by Composite, Composite
expended
approximately $138,182,745 (excluding commissions) of its working
capital. In acquiring 2,974,800 Common Shares owned by Valence,
Valence expended approximately $98,014,838 (excluding commissions)
of its
working capital. In acquiring listed call options exercisable
for 25,000 Common Shares, Valence expended approximately $117,500
(excluding commissions) of its working capital. In acquiring
819 Common Shares owned by Synoptic, Synoptic expended approximately
$27,477 (excluding commissions) of its working capital.
|
|||
Item
4.
|
Purpose
of Transaction
|
||
Composite,
Valence, and Synoptic made the purchases noted in Item 3 above for
investment purposes. Composite, Valence, and Synoptic will
review their investments in the Common Shares from time to time,
and,
subject to applicable law and regulation and depending upon certain
factors, including, without limitation, the financial performance
of the
Issuer, the availability and price of the Common Shares or other
securities related to the Issuer, and other general market and investment
conditions, Composite, Valence, and Synoptic may determine
to:
|
|||
●
|
acquire
additional Common Shares through open market purchases or
otherwise;
|
||
●
|
sell,
trade, engage in short selling of, hedge, or enter into any similar
transactions with respect to the Common Shares through the open market
or
otherwise; or
|
||
●
|
otherwise
engage or participate in a transaction with the purpose or effect
of
changing or influencing the control of the Issuer.
|
||
Such
transactions may take place at any time and without prior
notice. There can be no assurance, however, that any Reporting
Person will take any such actions.
|
|||
As
part of Composite’s, Valence’s, and Synoptic’s ongoing review of their
investments in the Common Shares, Composite, Valence, and Synoptic
will
from time to time hold talks or discussions with, write letters to
and
respond to inquiries from various parties, including, without limitation,
the Issuer’s Board of Directors, management or representatives, other
shareholders and other persons or entities, regarding the Issuer’s affairs
and strategic alternatives.
|
|||
Without
limiting the generality of the foregoing, Composite has sent a letter
to
Mr. Peter Lankau, the Chief Executive Officer of the Issuer, dated
July
27, 2007 (the “Issuer Letter”), expressing certain concerns with respect
to the current share price of the Common Shares. The Reporting
Persons believe that the true value of the Common Shares is being
discounted due to (a) an inefficient capital structure at the Issuer,
in
the form of net cash on hand retained for a potential strategic
acquisition transaction, (b) the Issuer’s publicly stated intention to
diversify away from pain management through a strategic acquisition
transaction, and (c) the perceived risk of genericization of the
Issuer’s
drug Lidoderm. The Reporting Persons believe that more
effectively deploying the Issuer’s net cash position in the near-term
could substantially improve its present and future valuation with
no risk
of impairing the ability to pursue a future acquisition
transaction. The Reporting Persons believe the company should
consider strategic alternatives prior to pursuing a transaction to
diversify beyond pain management. The Reporting Persons also
believe that the risk of genericization to Lidoderm’s business is
overstated.
|
|||
The
Reporting Persons have attached the Issuer Letter to this Schedule
13D as
Exhibit 4.
|
|||
Based
on the above-referenced Issuer Letter and other discussions or inquiries
that Composite, Valence, and Synoptic may undertake from time to
time, and
subject to applicable law and regulation and depending upon certain
factors, including, without limitation, the financial performance
of the
Issuer, the availability and price of the Common Shares or other
securities related to the Issuer, and other general market investment
conditions, Composite, Valence, and Synoptic may determine to pursue
various strategic alternatives in respect of their investments in
the
Issuer. Such actions may include, without limitation, direct or
indirect participation in the following:
|
|||
●
|
forming
and conducting potential strategic developments and plans related
to the
Issuer;
|
||
●
|
seeking
representation on the Board of Directors of the Issuer;
|
||
●
|
making
recommendations to the Issuer’s Board of Directors and management of the
Issuer concerning various business strategies, mergers, acquisitions,
dispositions, dividend policy, capital structure, the provisions
of the
Issuer’s Articles of Incorporation or Bylaws or other
matters;
|
||
●
|
seeking
to acquire control of the Issuer through a merger, proxy solicitation,
tender offer, exchange offer or otherwise;
|
||
●
|
restructuring
and effecting other significant transactions with respect to the
Issuer;
|
||
●
|
participating
in a “going-private” transaction;
|
||
●
|
taking
any other actions that could have the purpose or effect of directly
or
indirectly
changing or influencing control of the Issuer; or
|
||
●
|
providing
financing for any of the foregoing.
|
||
Such
transactions may take place at any time and without prior
notice. There can be no assurance, however, that the possible
courses of action expressed in the immediately preceding sentence
will be
pursued or, if pursued, will be consummated by Composite, Valence,
and
Synoptic or any other Reporting Person.
|
|||
Item
5.
|
Interest
in Securities of the Issuer
|
||
(a),
(b) Based upon the Issuer’s Form 10-Q, filed with the Securities and
Exchange Commission on May 10, 2007, there were 133,773,371 Common
Shares
issued and outstanding as of March 31, 2007. The 4,388,158
beneficially owned by Composite (the “Composite Shares”) represent
approximately 3.3% of the Common Shares issued and
outstanding. The 2,999,800 beneficially owned by Valence (the
“Valence Shares”) represent approximately 2.2% of the Common Shares issued
and outstanding.2 The
819 Common Shares beneficially owned by Synoptic (the “Synoptic Shares”)
represent approximately 0.0% of the Common Shares issued and
outstanding. The 7,544,410 Common Shares beneficially owned by
DESCO LP (the “Subject Shares”) represent approximately 5.6% of the Common
Shares issued and outstanding. The Subject Shares are comprised
of (i) the Composite Shares, (ii) the Valence Shares, (iii) the Synoptic
Shares, and (iv) 155,633 Common Shares under the management of DESIM
LLC
(the “DESIM Shares”).
|
|||
Composite
has the power to vote or to direct the vote of (and the power to
dispose
or direct the disposition of) the Composite Shares. Valence has
the power to vote or to direct the vote of (and the power to dispose
or
direct the disposition of) the Valence Shares. Synoptic has the
power to vote or to direct the vote of (and the power to dispose
or direct
the disposition of) the Synoptic Shares. DESIM LLC has the
power to vote or to direct the vote of (and the power to dispose
or direct
the disposition of) 103,433 of the DESIM Shares, and the shared power
to
dispose or direct the disposition of (but not the power to vote or
to
direct the vote of) 52,200 of the DESIM Shares. Composite
disclaims beneficial ownership of the Common Shares beneficially
owned by
Valence, Synoptic, and DESIM LLC; Valence disclaims beneficial ownership
of the Common Shares beneficially owned by Composite, Synoptic, and
DESIM
LLC; Synoptic disclaims beneficial ownership of the Common Shares
beneficially owned by Composite, Valence, and DESIM LLC; and DESIM
LLC
disclaims beneficial ownership of the Common Shares beneficially
owned by
Composite, Valence, and Synoptic.
|
|||
DESCO
LP, as managing member and investment adviser of Valence, investment
adviser of Composite and Synoptic, and managing member of DESIM LLC,
may
be deemed to have the shared power to vote or direct the vote of
(and the
shared power to dispose or direct the disposition of) the Composite
Shares, the Valence Shares, and the Synoptic Shares, and the shared
power
to vote or direct the vote of (and the power to dispose or direct
the
disposition of) 103,433 of the DESIM Shares, and the shared power
to
dispose or direct the disposition of (but not the power to vote or
to
direct the vote of) 52,200 of the DESIM Shares. DESCO LLC, as
Composite’s and Synoptic’s managing member, may be deemed to have the
shared power to vote or direct the vote of (and the shared power
to
dispose or direct the disposition of) the Composite Shares and the
Synoptic Shares. As managing member of DESCO LLC, DESCO II,
Inc. may be deemed to have the shared power to vote or to direct
the vote
of (and the shared power to dispose or direct the disposition of)
the
Composite Shares and the Synoptic Shares. As general partner of
DESCO LP, DESCO, Inc. may be deemed to have the shared power to vote
or to
direct the vote of (and the shared power to dispose or direct the
disposition of) the Composite Shares, the Valence Shares, and the
Synoptic
Shares, and the shared power to vote or direct the vote of (and the
power
to dispose or direct the disposition of) 103,433 of the DESIM Shares,
and
the shared power to dispose or direct the disposition of (but not
the
power to vote or to direct the vote of) 52,200 of the DESIM
Shares. None of DESCO LP, DESCO LLC, DESCO, Inc., or DESCO II,
Inc., owns any Common Shares directly, and each such entity disclaims
beneficial ownership of the Composite Shares, the Valence Shares,
the
Synoptic Shares, and the DESIM Shares.
|
|||
David
E. Shaw does not own any shares directly. By virtue of David E.
Shaw’s position as President and sole shareholder of DESCO Inc., which
is
the general partner of DESCO LP, which in turn is the managing member
and
investment adviser of Valence and the investment adviser of Composite,
Synoptic and DESIM, and by virtue of David E. Shaw’s position as President
and sole shareholder of DESCO II, Inc., which is the managing member
of
DESCO LLC, which in turn is the managing member of Composite and
Synoptic,
David E. Shaw may be deemed to have the shared power to vote or direct
the
vote of (and the shared power to dispose or direct the disposition
of) the
Composite Shares, the Valence Shares and the Synoptic Shares, and
the
shared power to vote or direct the vote of (and the power to dispose
or
direct the disposition of), 103,433 of the DESIM Shares, and the
shared
power to dispose or direct the disposition of (but not the power
to vote
or to direct the vote of) 52,200 of the DESIM Shares. David E.
Shaw disclaims beneficial ownership of the Composite Shares, the
Valence
Shares, the Synoptic Shares, and the DESIM Shares.
|
|||
As
of the date hereof, neither any Reporting Person nor, to the best
knowledge of any Reporting Person, any of the persons set forth in
Item 2
owns any Common Shares other than those set forth in this Item
5.
|
|||
(c)
The trading dates, number of Common Shares purchased or sold, and
the
price per share for all transactions by the Reporting Persons in
the
Common Shares within the last 60 days, which were all brokered
transactions, are set forth below:
|
|||
Name
|
Date
|
Price
per Share
|
Number
of Shares Purchased/
(Sold)
|
|||
Synoptic
|
5/29/2007
|
$33.72
|
(25)
|
|||
Synoptic
|
5/29/2007
|
$33.86
|
12
|
|||
Synoptic
|
5/29/2007
|
$33.91
|
13
|
|||
Synoptic
|
5/30/2007
|
$33.60
|
(33)
|
|||
Synoptic
|
5/30/2007
|
$33.63
|
(200)
|
|||
Synoptic
|
5/30/2007
|
$33.81
|
243
|
|||
Composite
|
5/31/2007
|
$35.00
|
(10,000)
|
|||
Composite
|
5/31/2007
|
$35.04
|
(38,200)
|
|||
Composite
|
5/31/2007
|
$35.14
|
(10,000)
|
|||
Composite
|
5/31/2007
|
$35.24
|
(11,800)
|
|||
Composite
|
5/31/2007
|
$35.32
|
(120,000)
|
|||
DESIM
LLC
|
5/31/2007
|
$34.70
|
3,400
|
|||
Synoptic
|
5/31/2007
|
$34.69
|
88
|
|||
Synoptic
|
5/31/2007
|
$34.72
|
(200)
|
|||
Synoptic
|
5/31/2007
|
$34.80
|
(83)
|
|||
Valence
|
5/31/2007
|
$34.93
|
(23,800)
|
|||
Valence
|
5/31/2007
|
$34.99
|
(23,800)
|
|||
Valence
|
5/31/2007
|
$35.05
|
(23,800)
|
|||
Valence
|
5/31/2007
|
$35.11
|
(23,800)
|
|||
Valence
|
5/31/2007
|
$35.18
|
(65,300)
|
|||
Valence
|
5/31/2007
|
$35.29
|
(100,000)
|
|||
Valence
|
5/31/2007
|
$35.32
|
(391,800)
|
|||
DESIM
LLC
|
6/1/2007
|
$34.93
|
(1,200)
|
|||
DESIM
LLC
|
6/1/2007
|
$34.94
|
(3,100)
|
|||
DESIM
LLC
|
6/1/2007
|
$34.96
|
(1,100)
|
|||
DESIM
LLC
|
6/1/2007
|
$34.99
|
(1,500)
|
|||
DESIM
LLC
|
6/1/2007
|
$35.06
|
(300)
|
|||
DESIM
LLC
|
6/1/2007
|
$35.07
|
(300)
|
|||
Synoptic
|
6/1/2007
|
$35.00
|
28
|
|||
Valence
|
6/1/2007
|
$34.87
|
638
|
|||
Valence
|
6/1/2007
|
$34.89
|
500
|
|||
Valence
|
6/1/2007
|
$34.90
|
3,100
|
|||
Valence
|
6/1/2007
|
$34.91
|
1,400
|
|||
Valence
|
6/1/2007
|
$34.94
|
500
|
|||
Valence
|
6/1/2007
|
$34.98
|
300
|
|||
Valence
|
6/1/2007
|
$34.99
|
200
|
|||
Valence
|
6/4/2007
|
$34.73
|
(400)
|
|||
Valence
|
6/4/2007
|
$34.74
|
(300)
|
|||
Valence
|
6/4/2007
|
$34.78
|
(300)
|
|||
Valence
|
6/4/2007
|
$34.82
|
(300)
|
|||
Valence
|
6/4/2007
|
$34.83
|
(1,000)
|
|||
Valence
|
6/4/2007
|
$34.84
|
(800)
|
|||
Valence
|
6/4/2007
|
$34.86
|
(300)
|
|||
Valence
|
6/4/2007
|
$34.87
|
(400)
|
|||
Valence
|
6/4/2007
|
$34.89
|
(600)
|
|||
Valence
|
6/4/2007
|
$34.90
|
(700)
|
|||
Valence
|
6/4/2007
|
$34.91
|
(1,000)
|
|||
Valence
|
6/4/2007
|
$34.95
|
(900)
|
|||
Valence
|
6/4/2007
|
$34.96
|
(300)
|
|||
Valence
|
6/4/2007
|
$34.98
|
(522)
|
|||
Valence
|
6/4/2007
|
$34.99
|
(500)
|
|||
Valence
|
6/4/2007
|
$35.00
|
(1,400)
|
|||
Valence
|
6/4/2007
|
$35.02
|
(300)
|
|||
Valence
|
6/4/2007
|
$35.04
|
(900)
|
|||
Valence
|
6/4/2007
|
$35.05
|
(200)
|
|||
Composite
|
6/7/2007
|
$34.21
|
100,000
|
|||
Synoptic
|
6/7/2007
|
$34.16
|
(84)
|
|||
Synoptic
|
6/7/2007
|
$34.17
|
186
|
|||
Valence
|
6/7/2007
|
$33.94
|
(300)
|
|||
Valence
|
6/7/2007
|
$33.95
|
(1,300)
|
|||
Valence
|
6/7/2007
|
$34.23
|
(900)
|
|||
Valence
|
6/7/2007
|
$34.31
|
(600)
|
|||
Valence
|
6/7/2007
|
$34.32
|
(600)
|
|||
Valence
|
6/7/2007
|
$34.37
|
(600)
|
|||
Valence
|
6/7/2007
|
$34.38
|
(600)
|
|||
Valence
|
6/7/2007
|
$34.40
|
(600)
|
|||
Valence
|
6/7/2007
|
$34.41
|
(400)
|
|||
Valence
|
6/7/2007
|
$34.43
|
(700)
|
|||
Valence
|
6/7/2007
|
$34.46
|
(500)
|
|||
Valence
|
6/7/2007
|
$34.47
|
(100)
|
|||
Valence
|
6/7/2007
|
$34.49
|
(1,900)
|
|||
Valence
|
6/7/2007
|
$34.50
|
(1,400)
|
|||
Valence
|
6/7/2007
|
$34.51
|
(600)
|
|||
Composite
|
6/8/2007
|
$33.94
|
100,000
|
|||
Synoptic
|
6/8/2007
|
$34.01
|
(90)
|
|||
Valence
|
6/8/2007
|
$33.83
|
(300)
|
|||
Valence
|
6/8/2007
|
$33.84
|
(300)
|
|||
Valence
|
6/8/2007
|
$33.85
|
(1,100)
|
|||
Valence
|
6/8/2007
|
$33.87
|
(300)
|
|||
Valence
|
6/8/2007
|
$33.88
|
(2,200)
|
|||
Valence
|
6/8/2007
|
$33.89
|
(1,800)
|
|||
Valence
|
6/8/2007
|
$33.90
|
(1,794)
|
|||
Valence
|
6/8/2007
|
$33.91
|
(1,000)
|
|||
Valence
|
6/8/2007
|
$33.92
|
(600)
|
|||
Valence
|
6/8/2007
|
$33.95
|
(500)
|
|||
Valence
|
6/8/2007
|
$33.96
|
(800)
|
|||
Valence
|
6/8/2007
|
$33.97
|
(600)
|
|||
Valence
|
6/8/2007
|
$33.98
|
(700)
|
|||
Valence
|
6/8/2007
|
$33.99
|
(1,200)
|
|||
Valence
|
6/8/2007
|
$34.00
|
(400)
|
|||
Valence
|
6/8/2007
|
$34.02
|
(100)
|
|||
Valence
|
6/8/2007
|
$34.04
|
(500)
|
|||
Valence
|
6/8/2007
|
$34.09
|
(400)
|
|||
Composite
|
6/11/2007
|
$33.94
|
100,000
|
|||
Composite
|
6/12/2007
|
$33.92
|
100,000
|
|||
Valence
|
6/12/2007
|
$33.84
|
(13,500)
|
|||
Synoptic
|
6/13/2007
|
$34.15
|
(400)
|
|||
Synoptic
|
6/14/2007
|
$34.29
|
(179)
|
|||
Synoptic
|
6/14/2007
|
$34.35
|
293
|
|||
Synoptic
|
6/14/2007
|
$34.59
|
170
|
|||
Valence
|
6/14/2007
|
$34.41
|
500
|
|||
Valence
|
6/14/2007
|
$34.42
|
300
|
|||
Valence
|
6/14/2007
|
$34.44
|
200
|
|||
Valence
|
6/14/2007
|
$34.46
|
300
|
|||
Valence
|
6/14/2007
|
$34.49
|
600
|
|||
Valence
|
6/14/2007
|
$34.51
|
800
|
|||
Valence
|
6/14/2007
|
$34.53
|
400
|
|||
Valence
|
6/14/2007
|
$34.54
|
400
|
|||
Valence
|
6/14/2007
|
$34.57
|
100
|
|||
Valence
|
6/14/2007
|
$34.60
|
900
|
|||
Valence
|
6/14/2007
|
$34.61
|
800
|
|||
Valence
|
6/14/2007
|
$34.62
|
500
|
|||
Valence
|
6/14/2007
|
$34.63
|
1,600
|
|||
Valence
|
6/14/2007
|
$34.65
|
900
|
|||
Valence
|
6/14/2007
|
$34.66
|
400
|
|||
Valence
|
6/14/2007
|
$34.69
|
700
|
|||
Synoptic
|
6/15/2007
|
$34.35
|
200
|
|||
Synoptic
|
6/15/2007
|
$34.39
|
16
|
|||
Synoptic
|
6/15/2007
|
$34.42
|
(100)
|
|||
Synoptic
|
6/15/2007
|
$34.53
|
(80)
|
|||
Valence
|
6/15/2007
|
$34.40
|
13,700
|
|||
Valence
|
6/15/2007
|
$34.44
|
1,500
|
|||
Valence
|
6/15/2007
|
$34.46
|
2,900
|
|||
Valence
|
6/15/2007
|
$34.48
|
1,000
|
|||
Valence
|
6/15/2007
|
$34.56
|
2,100
|
|||
Valence
|
6/15/2007
|
$34.57
|
700
|
|||
Valence
|
6/15/2007
|
$34.58
|
2,400
|
|||
Valence
|
6/15/2007
|
$34.59
|
500
|
|||
Synoptic
|
6/18/2007
|
$34.86
|
181
|
|||
Synoptic
|
6/18/2007
|
$34.87
|
(97)
|
|||
Synoptic
|
6/18/2007
|
$34.94
|
8
|
|||
Synoptic
|
6/18/2007
|
$34.96
|
100
|
|||
Valence
|
6/18/2007
|
$34.66
|
900
|
|||
Valence
|
6/18/2007
|
$34.67
|
3,000
|
|||
Valence
|
6/18/2007
|
$34.69
|
1,300
|
|||
Valence
|
6/18/2007
|
$34.71
|
1,400
|
|||
Valence
|
6/18/2007
|
$34.73
|
200
|
|||
Valence
|
6/18/2007
|
$34.74
|
100
|
|||
Valence
|
6/18/2007
|
$34.77
|
200
|
|||
Valence
|
6/18/2007
|
$34.80
|
1,300
|
|||
Valence
|
6/18/2007
|
$34.82
|
300
|
|||
Valence
|
6/18/2007
|
$34.84
|
1,700
|
|||
Valence
|
6/18/2007
|
$34.85
|
1,900
|
|||
Valence
|
6/18/2007
|
$34.86
|
1,000
|
|||
Valence
|
6/18/2007
|
$34.90
|
600
|
|||
Valence
|
6/18/2007
|
$34.91
|
1,500
|
|||
Valence
|
6/18/2007
|
$34.92
|
1,800
|
|||
Valence
|
6/18/2007
|
$34.95
|
600
|
|||
Valence
|
6/18/2007
|
$34.96
|
1,600
|
|||
Valence
|
6/18/2007
|
$34.97
|
2,000
|
|||
Valence
|
6/18/2007
|
$34.99
|
300
|
|||
Valence
|
6/18/2007
|
$35.01
|
550
|
|||
Valence
|
6/18/2007
|
$35.02
|
2,710
|
|||
Valence
|
6/18/2007
|
$35.03
|
1,200
|
|||
Valence
|
6/18/2007
|
$35.07
|
400
|
|||
Valence
|
6/18/2007
|
$35.10
|
300
|
|||
Valence
|
6/18/2007
|
$35.12
|
700
|
|||
Valence
|
6/18/2007
|
$35.14
|
1,500
|
|||
Valence
|
6/18/2007
|
$35.15
|
1,300
|
|||
Valence
|
6/18/2007
|
$35.17
|
300
|
|||
Valence
|
6/18/2007
|
$35.19
|
900
|
|||
Valence
|
6/18/2007
|
$35.23
|
200
|
|||
Valence
|
6/18/2007
|
$35.24
|
1,300
|
|||
Valence
|
6/18/2007
|
$35.25
|
300
|
|||
Valence
|
6/18/2007
|
$35.27
|
700
|
|||
Valence
|
6/18/2007
|
$35.30
|
900
|
|||
Valence
|
6/18/2007
|
$35.32
|
700
|
|||
Synoptic
|
6/19/2007
|
$34.50
|
(79)
|
|||
Synoptic
|
6/19/2007
|
$34.90
|
(100)
|
|||
Valence
|
6/19/2007
|
$34.23
|
700
|
|||
Valence
|
6/19/2007
|
$34.25
|
2,200
|
|||
Valence
|
6/19/2007
|
$34.26
|
400
|
|||
Valence
|
6/19/2007
|
$34.29
|
1,300
|
|||
Valence
|
6/19/2007
|
$34.30
|
600
|
|||
Valence
|
6/19/2007
|
$34.33
|
1,900
|
|||
Valence
|
6/19/2007
|
$34.35
|
900
|
|||
Valence
|
6/19/2007
|
$34.40
|
800
|
|||
Valence
|
6/19/2007
|
$34.46
|
445
|
|||
Valence
|
6/19/2007
|
$34.47
|
1,400
|
|||
Valence
|
6/19/2007
|
$34.50
|
2,158
|
|||
Valence
|
6/19/2007
|
$34.52
|
600
|
|||
Valence
|
6/19/2007
|
$34.53
|
500
|
|||
Valence
|
6/19/2007
|
$34.54
|
500
|
|||
Valence
|
6/19/2007
|
$34.55
|
600
|
|||
Valence
|
6/19/2007
|
$34.57
|
2,000
|
|||
Valence
|
6/19/2007
|
$34.58
|
3,400
|
|||
Valence
|
6/19/2007
|
$34.72
|
300
|
|||
Valence
|
6/19/2007
|
$34.73
|
800
|
|||
Valence
|
6/19/2007
|
$34.78
|
500
|
|||
Valence
|
6/19/2007
|
$34.79
|
1,400
|
|||
Valence
|
6/19/2007
|
$34.85
|
2,100
|
|||
Valence
|
6/19/2007
|
$34.88
|
200
|
|||
Valence
|
6/19/2007
|
$34.90
|
700
|
|||
Composite
|
6/20/2007
|
$34.06
|
45,000
|
|||
Composite
|
6/20/2007
|
$34.24
|
5,000
|
|||
Synoptic
|
6/20/2007
|
$33.99
|
100
|
|||
Synoptic
|
6/20/2007
|
$34.01
|
(52)
|
|||
Synoptic
|
6/20/2007
|
$34.04
|
100
|
|||
Synoptic
|
6/20/2007
|
$34.06
|
(127)
|
|||
Synoptic
|
6/20/2007
|
$34.11
|
(100)
|
|||
Synoptic
|
6/20/2007
|
$34.16
|
200
|
|||
Valence
|
6/20/2007
|
$33.97
|
700
|
|||
Valence
|
6/20/2007
|
$33.98
|
600
|
|||
Valence
|
6/20/2007
|
$33.99
|
2,800
|
|||
Valence
|
6/20/2007
|
$34.00
|
1,100
|
|||
Valence
|
6/20/2007
|
$34.01
|
4,500
|
|||
Valence
|
6/20/2007
|
$34.02
|
2,000
|
|||
Valence
|
6/20/2007
|
$34.03
|
400
|
|||
Valence
|
6/20/2007
|
$34.04
|
3,000
|
|||
Valence
|
6/20/2007
|
$34.05
|
3,500
|
|||
Valence
|
6/20/2007
|
$34.06
|
900
|
|||
Valence
|
6/20/2007
|
$34.07
|
2,100
|
|||
Valence
|
6/20/2007
|
$34.08
|
1,800
|
|||
Valence
|
6/20/2007
|
$34.09
|
1,100
|
|||
Valence
|
6/20/2007
|
$34.10
|
200
|
|||
Valence
|
6/20/2007
|
$34.11
|
1,000
|
|||
Valence
|
6/20/2007
|
$34.12
|
300
|
|||
Valence
|
6/20/2007
|
$34.13
|
600
|
|||
Valence
|
6/20/2007
|
$34.14
|
300
|
|||
Valence
|
6/20/2007
|
$34.15
|
3,352
|
|||
Valence
|
6/20/2007
|
$34.16
|
400
|
|||
Valence
|
6/20/2007
|
$34.17
|
300
|
|||
Valence
|
6/20/2007
|
$34.19
|
1,900
|
|||
Synoptic
|
6/21/2007
|
$34.51
|
(100)
|
|||
Synoptic
|
6/21/2007
|
$34.73
|
(100)
|
|||
Synoptic
|
6/21/2007
|
$34.77
|
300
|
|||
Synoptic
|
6/21/2007
|
$34.79
|
100
|
|||
Synoptic
|
6/21/2007
|
$34.80
|
(47)
|
|||
Synoptic
|
6/21/2007
|
$34.82
|
(219)
|
|||
Synoptic
|
6/21/2007
|
$34.84
|
100
|
|||
Valence
|
6/21/2007
|
$34.44
|
1,536
|
|||
Valence
|
6/21/2007
|
$34.49
|
571
|
|||
Valence
|
6/21/2007
|
$34.50
|
500
|
|||
Valence
|
6/21/2007
|
$34.51
|
1,400
|
|||
Valence
|
6/21/2007
|
$34.53
|
1,400
|
|||
Valence
|
6/21/2007
|
$34.54
|
1,700
|
|||
Valence
|
6/21/2007
|
$34.56
|
1,200
|
|||
Valence
|
6/21/2007
|
$34.58
|
1,000
|
|||
Valence
|
6/21/2007
|
$34.59
|
900
|
|||
Valence
|
6/21/2007
|
$34.60
|
1,400
|
|||
Valence
|
6/21/2007
|
$34.61
|
800
|
|||
Valence
|
6/21/2007
|
$34.63
|
387
|
|||
Valence
|
6/21/2007
|
$34.64
|
2,700
|
|||
Valence
|
6/21/2007
|
$34.65
|
2,000
|
|||
Valence
|
6/21/2007
|
$34.66
|
900
|
|||
Valence
|
6/21/2007
|
$34.67
|
300
|
|||
Valence
|
6/21/2007
|
$34.68
|
400
|
|||
Valence
|
6/21/2007
|
$34.69
|
1,100
|
|||
Valence
|
6/21/2007
|
$34.72
|
1
|
|||
Valence
|
6/21/2007
|
$34.74
|
1,000
|
|||
Valence
|
6/21/2007
|
$34.75
|
1,600
|
|||
Valence
|
6/21/2007
|
$34.76
|
1,200
|
|||
Valence
|
6/21/2007
|
$34.77
|
200
|
|||
Valence
|
6/21/2007
|
$34.78
|
300
|
|||
Valence
|
6/21/2007
|
$34.79
|
100
|
|||
Valence
|
6/21/2007
|
$34.80
|
700
|
|||
Valence
|
6/21/2007
|
$34.81
|
1,900
|
|||
Valence
|
6/21/2007
|
$34.82
|
800
|
|||
Valence
|
6/21/2007
|
$34.84
|
1,200
|
|||
Valence
|
6/21/2007
|
$34.85
|
500
|
|||
Composite
|
6/22/2007
|
$34.12
|
100,000
|
|||
Synoptic
|
6/22/2007
|
$34.14
|
65
|
|||
Synoptic
|
6/22/2007
|
$34.16
|
(321)
|
|||
Synoptic
|
6/22/2007
|
$34.40
|
(249)
|
|||
Synoptic
|
6/22/2007
|
$34.44
|
51
|
|||
Synoptic
|
6/22/2007
|
$34.50
|
287
|
|||
Synoptic
|
6/22/2007
|
$34.51
|
(390)
|
|||
Synoptic
|
6/22/2007
|
$34.53
|
(100)
|
|||
Synoptic
|
6/22/2007
|
$34.54
|
200
|
|||
Synoptic
|
6/22/2007
|
$34.56
|
400
|
|||
Synoptic
|
6/22/2007
|
$34.66
|
(19)
|
|||
Synoptic
|
6/22/2007
|
$34.67
|
(99)
|
|||
Synoptic
|
6/22/2007
|
$34.71
|
74
|
|||
Valence
|
6/22/2007
|
$34.10
|
1,200
|
|||
Valence
|
6/22/2007
|
$34.13
|
700
|
|||
Valence
|
6/22/2007
|
$34.15
|
3,700
|
|||
Valence
|
6/22/2007
|
$34.16
|
1,200
|
|||
Valence
|
6/22/2007
|
$34.17
|
700
|
|||
Valence
|
6/22/2007
|
$34.18
|
1,400
|
|||
Valence
|
6/22/2007
|
$34.19
|
100
|
|||
Valence
|
6/22/2007
|
$34.20
|
600
|
|||
Valence
|
6/22/2007
|
$34.21
|
500
|
|||
Valence
|
6/22/2007
|
$34.23
|
400
|
|||
Valence
|
6/22/2007
|
$34.25
|
200
|
|||
Valence
|
6/22/2007
|
$34.27
|
300
|
|||
Valence
|
6/22/2007
|
$34.35
|
800
|
|||
Valence
|
6/22/2007
|
$34.41
|
1,300
|
|||
Valence
|
6/22/2007
|
$34.43
|
1,600
|
|||
Valence
|
6/22/2007
|
$34.45
|
2,026
|
|||
Valence
|
6/22/2007
|
$34.46
|
1,100
|
|||
Valence
|
6/22/2007
|
$34.48
|
1,100
|
|||
Valence
|
6/22/2007
|
$34.50
|
4,220
|
|||
Valence
|
6/22/2007
|
$34.51
|
800
|
|||
Valence
|
6/22/2007
|
$34.52
|
1,500
|
|||
Valence
|
6/22/2007
|
$34.53
|
400
|
|||
Valence
|
6/22/2007
|
$34.54
|
629
|
|||
Valence
|
6/22/2007
|
$34.57
|
1,200
|
|||
Valence
|
6/22/2007
|
$34.58
|
1,400
|
|||
Valence
|
6/22/2007
|
$34.61
|
700
|
|||
Synoptic
|
6/25/2007
|
$34.08
|
100
|
|||
Synoptic
|
6/25/2007
|
$34.09
|
(100)
|
|||
Synoptic
|
6/25/2007
|
$34.13
|
(100)
|
|||
Composite
|
6/26/2007
|
$35.01
|
(107,357)
|
|||
Synoptic
|
6/26/2007
|
$34.40
|
(300)
|
|||
Synoptic
|
6/26/2007
|
$34.85
|
300
|
|||
Synoptic
|
6/26/2007
|
$34.88
|
100
|
|||
Synoptic
|
6/26/2007
|
$34.94
|
154
|
|||
Synoptic
|
6/26/2007
|
$34.95
|
222
|
|||
Synoptic
|
6/26/2007
|
$35.00
|
124
|
|||
Synoptic
|
6/26/2007
|
$35.04
|
100
|
|||
Valence
|
6/26/2007
|
$34.83
|
500
|
|||
Valence
|
6/26/2007
|
$34.84
|
1,696
|
|||
Valence
|
6/26/2007
|
$34.85
|
2,400
|
|||
Valence
|
6/26/2007
|
$34.88
|
1,682
|
|||
Valence
|
6/26/2007
|
$34.89
|
1,500
|
|||
Valence
|
6/26/2007
|
$34.92
|
1,300
|
|||
Valence
|
6/26/2007
|
$34.93
|
1,400
|
|||
Valence
|
6/26/2007
|
$34.94
|
2,300
|
|||
Valence
|
6/26/2007
|
$34.95
|
1,600
|
|||
Valence
|
6/26/2007
|
$34.96
|
1,300
|
|||
Valence
|
6/26/2007
|
$34.97
|
1,800
|
|||
Valence
|
6/26/2007
|
$34.98
|
3,200
|
|||
Valence
|
6/26/2007
|
$34.99
|
1,500
|
|||
Valence
|
6/26/2007
|
$35.00
|
7,255
|
|||
Valence
|
6/26/2007
|
$35.01
|
2,800
|
|||
Valence
|
6/26/2007
|
$35.02
|
1,100
|
|||
Valence
|
6/26/2007
|
$35.03
|
100
|
|||
Valence
|
6/26/2007
|
$35.04
|
2,800
|
|||
Valence
|
6/26/2007
|
$35.05
|
1,200
|
|||
Synoptic
|
6/27/2007
|
$33.91
|
(59)
|
|||
Synoptic
|
6/27/2007
|
$33.93
|
100
|
|||
Synoptic
|
6/27/2007
|
$33.99
|
200
|
|||
Synoptic
|
6/27/2007
|
$34.00
|
100
|
|||
Synoptic
|
6/27/2007
|
$34.01
|
(200)
|
|||
Synoptic
|
6/27/2007
|
$34.02
|
100
|
|||
Synoptic
|
6/27/2007
|
$34.04
|
(100)
|
|||
Synoptic
|
6/27/2007
|
$34.04
|
100
|
|||
Synoptic
|
6/27/2007
|
$34.05
|
(47)
|
|||
Synoptic
|
6/27/2007
|
$34.19
|
300
|
|||
Synoptic
|
6/27/2007
|
$34.22
|
(200)
|
|||
Synoptic
|
6/27/2007
|
$34.23
|
(100)
|
|||
Synoptic
|
6/27/2007
|
$34.60
|
(400)
|
|||
Synoptic
|
6/27/2007
|
$34.73
|
(100)
|
|||
Valence
|
6/27/2007
|
$33.79
|
100
|
|||
Valence
|
6/27/2007
|
$33.80
|
7,500
|
|||
Valence
|
6/27/2007
|
$33.81
|
1,100
|
|||
Valence
|
6/27/2007
|
$33.83
|
1,700
|
|||
Valence
|
6/27/2007
|
$33.86
|
1,300
|
|||
Valence
|
6/27/2007
|
$33.90
|
4,000
|
|||
Valence
|
6/27/2007
|
$33.92
|
700
|
|||
Valence
|
6/27/2007
|
$33.93
|
400
|
|||
Valence
|
6/27/2007
|
$33.94
|
700
|
|||
Valence
|
6/27/2007
|
$33.95
|
2,800
|
|||
Valence
|
6/27/2007
|
$33.96
|
800
|
|||
Valence
|
6/27/2007
|
$33.97
|
500
|
|||
Valence
|
6/27/2007
|
$33.99
|
4,600
|
|||
Valence
|
6/27/2007
|
$34.00
|
4,800
|
|||
Valence
|
6/27/2007
|
$34.01
|
4,900
|
|||
Valence
|
6/27/2007
|
$34.02
|
3,700
|
|||
Valence
|
6/27/2007
|
$34.03
|
2,510
|
|||
Valence
|
6/27/2007
|
$34.04
|
1,900
|
|||
Valence
|
6/27/2007
|
$34.05
|
4,600
|
|||
Valence
|
6/27/2007
|
$34.07
|
1,600
|
|||
Valence
|
6/27/2007
|
$34.08
|
1,900
|
|||
Valence
|
6/27/2007
|
$34.12
|
300
|
|||
Valence
|
6/27/2007
|
$34.14
|
3,100
|
|||
Valence
|
6/27/2007
|
$34.16
|
1,800
|
|||
Valence
|
6/27/2007
|
$34.17
|
1,600
|
|||
Valence
|
6/27/2007
|
$34.18
|
5,600
|
|||
Valence
|
6/27/2007
|
$34.19
|
4,700
|
|||
Valence
|
6/27/2007
|
$34.20
|
1,600
|
|||
Valence
|
6/27/2007
|
$34.21
|
800
|
|||
Valence
|
6/27/2007
|
$34.22
|
1,100
|
|||
Valence
|
6/27/2007
|
$34.23
|
1,900
|
|||
Valence
|
6/27/2007
|
$34.24
|
1,590
|
|||
Valence
|
6/27/2007
|
$34.25
|
1,200
|
|||
Valence
|
6/27/2007
|
$34.26
|
900
|
|||
Valence
|
6/27/2007
|
$34.27
|
100
|
|||
Valence
|
6/27/2007
|
$34.28
|
700
|
|||
Valence
|
6/27/2007
|
$34.29
|
2,000
|
|||
Valence
|
6/27/2007
|
$34.30
|
1,500
|
|||
Valence
|
6/27/2007
|
$34.31
|
900
|
|||
Valence
|
6/27/2007
|
$34.32
|
600
|
|||
Valence
|
6/27/2007
|
$34.33
|
1,500
|
|||
Synoptic
|
6/28/2007
|
$34.08
|
(24)
|
|||
Valence
|
6/28/2007
|
$33.89
|
125,000
|
|||
Synoptic
|
6/29/2007
|
$34.29
|
113
|
|||
Synoptic
|
6/29/2007
|
$34.38
|
32
|
|||
Synoptic
|
6/29/2007
|
$34.44
|
148
|
|||
Synoptic
|
6/29/2007
|
$34.45
|
(450)
|
|||
Synoptic
|
6/29/2007
|
$34.63
|
(100)
|
|||
Valence
|
6/29/2007
|
$34.09
|
800
|
|||
Valence
|
6/29/2007
|
$34.15
|
1,100
|
|||
Valence
|
6/29/2007
|
$34.18
|
1,500
|
|||
Valence
|
6/29/2007
|
$34.31
|
(1,300)
|
|||
Valence
|
6/29/2007
|
$34.44
|
100,000
|
|||
Synoptic
|
7/2/2007
|
$34.41
|
(36)
|
|||
Synoptic
|
7/2/2007
|
$34.46
|
(36)
|
|||
Synoptic
|
7/2/2007
|
$34.46
|
56
|
|||
Valence
|
7/2/2007
|
$34.38
|
50,000
|
|||
Valence
|
7/2/2007
|
$34.42
|
100
|
|||
Valence
|
7/2/2007
|
$34.49
|
400
|
|||
Valence
|
7/2/2007
|
$34.51
|
600
|
|||
Valence
|
7/2/2007
|
$34.53
|
2,630
|
|||
Valence
|
7/2/2007
|
$34.55
|
600
|
|||
Synoptic
|
7/3/2007
|
$34.87
|
183
|
|||
Synoptic
|
7/3/2007
|
$34.88
|
56
|
|||
Synoptic
|
7/3/2007
|
$35.02
|
84
|
|||
Valence
|
7/3/2007
|
$34.86
|
1,000
|
|||
Valence
|
7/3/2007
|
$34.87
|
400
|
|||
Valence
|
7/3/2007
|
$34.88
|
2,300
|
|||
Valence
|
7/3/2007
|
$34.90
|
1,300
|
|||
Valence
|
7/3/2007
|
$34.97
|
1,000
|
|||
Valence
|
7/3/2007
|
$34.98
|
3,200
|
|||
Valence
|
7/3/2007
|
$34.99
|
2,300
|
|||
Valence
|
7/3/2007
|
$35.00
|
1,500
|
|||
Valence
|
7/3/2007
|
$35.01
|
400
|
|||
Valence
|
7/3/2007
|
$35.02
|
2,900
|
|||
Valence
|
7/3/2007
|
$35.03
|
3,200
|
|||
Valence
|
7/3/2007
|
$35.04
|
400
|
|||
Valence
|
7/3/2007
|
$35.06
|
1,600
|
|||
Valence
|
7/3/2007
|
$35.07
|
1,000
|
|||
Synoptic
|
7/5/2007
|
$34.43
|
(2)
|
|||
Synoptic
|
7/5/2007
|
$34.61
|
100
|
|||
Synoptic
|
7/5/2007
|
$34.71
|
(24)
|
|||
Synoptic
|
7/5/2007
|
$34.88
|
(372)
|
|||
Valence
|
7/5/2007
|
$34.42
|
2,800
|
|||
Valence
|
7/5/2007
|
$34.48
|
1,600
|
|||
Valence
|
7/5/2007
|
$34.50
|
600
|
|||
Valence
|
7/5/2007
|
$34.52
|
2,400
|
|||
Valence
|
7/5/2007
|
$34.53
|
500
|
|||
Valence
|
7/5/2007
|
$34.59
|
2,300
|
|||
Valence
|
7/5/2007
|
$34.61
|
400
|
|||
Valence
|
7/5/2007
|
$34.63
|
1,800
|
|||
Valence
|
7/5/2007
|
$34.65
|
2,100
|
|||
Valence
|
7/5/2007
|
$34.66
|
2,918
|
|||
Valence
|
7/5/2007
|
$34.67
|
600
|
|||
Valence
|
7/5/2007
|
$34.68
|
800
|
|||
Valence
|
7/5/2007
|
$34.69
|
800
|
|||
Valence
|
7/5/2007
|
$34.70
|
500
|
|||
Valence
|
7/5/2007
|
$34.71
|
100
|
|||
Valence
|
7/5/2007
|
$34.72
|
1,800
|
|||
Valence
|
7/5/2007
|
$34.73
|
1,500
|
|||
Valence
|
7/5/2007
|
$34.74
|
3,200
|
|||
Valence
|
7/5/2007
|
$34.75
|
530
|
|||
Valence
|
7/5/2007
|
$34.77
|
400
|
|||
Valence
|
7/5/2007
|
$34.82
|
800
|
|||
Valence
|
7/5/2007
|
$34.83
|
1,000
|
|||
Valence
|
7/5/2007
|
$34.84
|
1,700
|
|||
Valence
|
7/5/2007
|
$34.85
|
124
|
|||
Valence
|
7/5/2007
|
$34.89
|
700
|
|||
Valence
|
7/5/2007
|
$34.90
|
1,000
|
|||
Valence
|
7/5/2007
|
$34.99
|
2,600
|
|||
Valence
|
7/5/2007
|
$35.01
|
500
|
|||
Valence
|
7/5/2007
|
$35.03
|
1,000
|
|||
Valence
|
7/5/2007
|
$35.04
|
400
|
|||
Synoptic
|
7/6/2007
|
$34.47
|
56
|
|||
Valence
|
7/6/2007
|
$34.26
|
1,700
|
|||
Valence
|
7/6/2007
|
$34.30
|
800
|
|||
Valence
|
7/6/2007
|
$34.31
|
2,400
|
|||
Valence
|
7/6/2007
|
$34.33
|
900
|
|||
Valence
|
7/6/2007
|
$34.34
|
1,300
|
|||
Valence
|
7/6/2007
|
$34.36
|
500
|
|||
Valence
|
7/6/2007
|
$34.38
|
1,400
|
|||
Valence
|
7/6/2007
|
$34.39
|
2,267
|
|||
Valence
|
7/6/2007
|
$34.40
|
2,800
|
|||
Valence
|
7/6/2007
|
$34.41
|
1,900
|
|||
Valence
|
7/6/2007
|
$34.42
|
2,000
|
|||
Valence
|
7/6/2007
|
$34.43
|
800
|
|||
Valence
|
7/6/2007
|
$34.45
|
1,727
|
|||
Valence
|
7/6/2007
|
$34.46
|
1,000
|
|||
Valence
|
7/6/2007
|
$34.47
|
800
|
|||
Valence
|
7/6/2007
|
$34.48
|
700
|
|||
Valence
|
7/6/2007
|
$34.49
|
600
|
|||
Valence
|
7/6/2007
|
$34.52
|
1,400
|
|||
Valence
|
7/6/2007
|
$34.53
|
200
|
|||
Valence
|
7/6/2007
|
$34.55
|
300
|
|||
Valence
|
7/6/2007
|
$34.58
|
500
|
|||
Valence
|
7/6/2007
|
$34.59
|
1,700
|
|||
Synoptic
|
7/9/2007
|
$34.63
|
100
|
|||
Synoptic
|
7/9/2007
|
$34.69
|
63
|
|||
Synoptic
|
7/9/2007
|
$34.73
|
30
|
|||
Valence
|
7/9/2007
|
$34.52
|
443
|
|||
Valence
|
7/9/2007
|
$34.57
|
1,000
|
|||
Valence
|
7/9/2007
|
$34.58
|
600
|
|||
Valence
|
7/9/2007
|
$34.59
|
700
|
|||
Valence
|
7/9/2007
|
$34.60
|
2,700
|
|||
Valence
|
7/9/2007
|
$34.61
|
1,500
|
|||
Valence
|
7/9/2007
|
$34.62
|
1,200
|
|||
Valence
|
7/9/2007
|
$34.63
|
5,300
|
|||
Valence
|
7/9/2007
|
$34.65
|
1,600
|
|||
Valence
|
7/9/2007
|
$34.66
|
1,529
|
|||
Valence
|
7/9/2007
|
$34.68
|
1,100
|
|||
Valence
|
7/9/2007
|
$34.69
|
2,000
|
|||
Valence
|
7/9/2007
|
$34.71
|
5,200
|
|||
Valence
|
7/9/2007
|
$34.72
|
1,800
|
|||
Valence
|
7/9/2007
|
$34.73
|
2,090
|
|||
Valence
|
7/9/2007
|
$34.74
|
2,000
|
|||
Valence
|
7/9/2007
|
$34.76
|
1,300
|
|||
Valence
|
7/9/2007
|
$34.77
|
100
|
|||
Valence
|
7/9/2007
|
$34.78
|
900
|
|||
Valence
|
7/9/2007
|
$34.80
|
1,200
|
|||
Valence
|
7/9/2007
|
$34.82
|
2,900
|
|||
Synoptic
|
7/10/2007
|
$34.58
|
(86)
|
|||
Valence
|
7/10/2007
|
$34.46
|
600
|
|||
Valence
|
7/10/2007
|
$34.57
|
1,200
|
|||
Valence
|
7/10/2007
|
$34.58
|
600
|
|||
Valence
|
7/10/2007
|
$34.62
|
1,000
|
|||
Valence
|
7/10/2007
|
$34.73
|
1,700
|
|||
Valence
|
7/10/2007
|
$34.78
|
1,700
|
|||
Valence
|
7/10/2007
|
$34.79
|
700
|
|||
Valence
|
7/10/2007
|
$34.80
|
200
|
|||
Valence
|
7/10/2007
|
$34.81
|
700
|
|||
Valence
|
7/10/2007
|
$34.85
|
400
|
|||
Valence
|
7/10/2007
|
$34.86
|
400
|
|||
Valence
|
7/10/2007
|
$34.87
|
1,200
|
|||
Valence
|
7/10/2007
|
$34.88
|
1,800
|
|||
Valence
|
7/10/2007
|
$34.91
|
400
|
|||
Valence
|
7/10/2007
|
$34.95
|
600
|
|||
Valence
|
7/10/2007
|
$34.96
|
700
|
|||
Valence
|
7/10/2007
|
$34.97
|
300
|
|||
Valence
|
7/10/2007
|
$35.00
|
2,600
|
|||
Valence
|
7/10/2007
|
$35.04
|
2,100
|
|||
Valence
|
7/10/2007
|
$35.06
|
400
|
|||
Valence
|
7/10/2007
|
$35.07
|
300
|
|||
Valence
|
7/10/2007
|
$35.09
|
1,100
|
|||
Valence
|
7/10/2007
|
$35.10
|
2,300
|
|||
Valence
|
7/10/2007
|
$35.11
|
300
|
|||
Valence
|
7/10/2007
|
$35.12
|
1,300
|
|||
Valence
|
7/10/2007
|
$35.13
|
2,700
|
|||
Valence
|
7/10/2007
|
$35.15
|
3,200
|
|||
Valence
|
7/10/2007
|
$35.16
|
2,800
|
|||
Valence
|
7/10/2007
|
$35.17
|
2,100
|
|||
Valence
|
7/10/2007
|
$35.18
|
1,100
|
|||
Composite
|
7/11/2007
|
$34.70
|
(25,000)
|
|||
Composite
|
7/11/2007
|
$34.72
|
(16,080)
|
|||
Composite
|
7/11/2007
|
$34.73
|
(16,532)
|
|||
Synoptic
|
7/11/2007
|
$34.59
|
(89)
|
|||
Synoptic
|
7/11/2007
|
$34.64
|
(227)
|
|||
Synoptic
|
7/11/2007
|
$34.68
|
(459)
|
|||
Synoptic
|
7/11/2007
|
$34.68
|
100
|
|||
Synoptic
|
7/11/2007
|
$34.69
|
(83)
|
|||
Synoptic
|
7/11/2007
|
$34.70
|
137
|
|||
Synoptic
|
7/11/2007
|
$34.71
|
300
|
|||
Synoptic
|
7/11/2007
|
$34.72
|
204
|
|||
Synoptic
|
7/11/2007
|
$34.73
|
21
|
|||
Synoptic
|
7/11/2007
|
$34.74
|
300
|
|||
Valence
|
7/11/2007
|
$34.50
|
290
|
|||
Valence
|
7/11/2007
|
$34.51
|
900
|
|||
Valence
|
7/11/2007
|
$34.54
|
700
|
|||
Valence
|
7/11/2007
|
$34.57
|
1,700
|
|||
Valence
|
7/11/2007
|
$34.58
|
500
|
|||
Valence
|
7/11/2007
|
$34.60
|
2,200
|
|||
Valence
|
7/11/2007
|
$34.61
|
200
|
|||
Valence
|
7/11/2007
|
$34.62
|
1,400
|
|||
Valence
|
7/11/2007
|
$34.64
|
500
|
|||
Valence
|
7/11/2007
|
$34.66
|
400
|
|||
Valence
|
7/11/2007
|
$34.67
|
2,564
|
|||
Valence
|
7/11/2007
|
$34.68
|
3,100
|
|||
Valence
|
7/11/2007
|
$34.69
|
7,600
|
|||
Valence
|
7/11/2007
|
$34.70
|
1,200
|
|||
Valence
|
7/11/2007
|
$34.71
|
1,800
|
|||
Valence
|
7/11/2007
|
$34.72
|
2,100
|
|||
Valence
|
7/11/2007
|
$34.73
|
3,000
|
|||
Valence
|
7/11/2007
|
$34.74
|
1,000
|
|||
Valence
|
7/11/2007
|
$34.78
|
200
|
|||
Valence
|
7/11/2007
|
$34.79
|
300
|
|||
Composite
|
7/12/2007
|
$33.50
|
35,000
|
|||
Composite
|
7/12/2007
|
$33.52
|
13,574
|
|||
Composite
|
7/12/2007
|
$33.54
|
2,586
|
|||
Composite
|
7/12/2007
|
$33.64
|
15,000
|
|||
Composite
|
7/12/2007
|
$33.70
|
30,000
|
|||
Composite
|
7/12/2007
|
$33.78
|
800
|
|||
Composite
|
7/12/2007
|
$33.87
|
11,800
|
|||
Composite
|
7/12/2007
|
$33.95
|
20,315
|
|||
Composite
|
7/12/2007
|
$33.99
|
3,461
|
|||
DESIM
LLC
|
7/12/2007
|
$33.48
|
500
|
|||
DESIM
LLC
|
7/12/2007
|
$33.50
|
300
|
|||
DESIM
LLC
|
7/12/2007
|
$33.51
|
200
|
|||
DESIM
LLC
|
7/12/2007
|
$33.52
|
600
|
|||
Synoptic
|
7/12/2007
|
$32.78
|
(100)
|
|||
Synoptic
|
7/12/2007
|
$32.80
|
(16)
|
|||
Synoptic
|
7/12/2007
|
$32.96
|
200
|
|||
Synoptic
|
7/12/2007
|
$33.10
|
400
|
|||
Synoptic
|
7/12/2007
|
$33.25
|
(379)
|
|||
Synoptic
|
7/12/2007
|
$33.48
|
(200)
|
|||
Synoptic
|
7/12/2007
|
$33.50
|
(20)
|
|||
Synoptic
|
7/12/2007
|
$33.57
|
(208)
|
|||
Synoptic
|
7/12/2007
|
$33.59
|
(136)
|
|||
Synoptic
|
7/12/2007
|
$33.65
|
100
|
|||
Synoptic
|
7/12/2007
|
$33.70
|
(100)
|
|||
Synoptic
|
7/12/2007
|
$33.75
|
(100)
|
|||
Synoptic
|
7/12/2007
|
$33.75
|
31
|
|||
Synoptic
|
7/12/2007
|
$33.85
|
600
|
|||
Synoptic
|
7/12/2007
|
$33.98
|
61
|
|||
Synoptic
|
7/12/2007
|
$34.16
|
100
|
|||
Valence
|
7/12/2007
|
$33.52
|
39,300
|
|||
Valence
|
7/12/2007
|
$33.62
|
4,715
|
|||
Valence
|
7/12/2007
|
$33.64
|
15,000
|
|||
Valence
|
7/12/2007
|
$33.67
|
50,000
|
|||
Valence
|
7/12/2007
|
$33.88
|
3,827
|
|||
Valence
|
7/12/2007
|
$34.00
|
50,000
|
|||
Valence
|
7/12/2007
|
$34.70
|
(36,352)
|
|||
Valence
|
7/12/2007
|
$34.70
|
36,352
|
|||
Synoptic
|
7/13/2007
|
$34.11
|
100
|
|||
Synoptic
|
7/13/2007
|
$34.17
|
(441)
|
|||
Synoptic
|
7/13/2007
|
$34.18
|
15
|
|||
Synoptic
|
7/13/2007
|
$34.26
|
(293)
|
|||
Synoptic
|
7/13/2007
|
$34.27
|
(121)
|
|||
Synoptic
|
7/13/2007
|
$34.28
|
(29)
|
|||
Synoptic
|
7/13/2007
|
$34.39
|
(100)
|
|||
Valence
|
7/13/2007
|
$34.01
|
1,500
|
|||
Valence
|
7/13/2007
|
$34.07
|
25,000
|
|||
Synoptic
|
7/16/2007
|
$34.08
|
200
|
|||
Synoptic
|
7/16/2007
|
$34.26
|
(200)
|
|||
Synoptic
|
7/16/2007
|
$34.28
|
(13)
|
|||
Synoptic
|
7/16/2007
|
$34.32
|
100
|
|||
Synoptic
|
7/16/2007
|
$34.34
|
(100)
|
|||
Synoptic
|
7/16/2007
|
$34.42
|
39
|
|||
Synoptic
|
7/16/2007
|
$34.45
|
33
|
|||
Synoptic
|
7/16/2007
|
$34.46
|
65
|
|||
Synoptic
|
7/16/2007
|
$34.47
|
62
|
|||
Valence
|
7/16/2007
|
$33.94
|
200
|
|||
Valence
|
7/16/2007
|
$33.95
|
2,630
|
|||
Valence
|
7/16/2007
|
$34.14
|
4,983
|
|||
Synoptic
|
7/17/2007
|
$34.15
|
15
|
|||
Synoptic
|
7/17/2007
|
$34.20
|
40
|
|||
Synoptic
|
7/17/2007
|
$34.32
|
(329)
|
|||
Synoptic
|
7/17/2007
|
$34.35
|
283
|
|||
Synoptic
|
7/17/2007
|
$34.43
|
(100)
|
|||
Synoptic
|
7/17/2007
|
$34.45
|
(48)
|
|||
Valence
|
7/17/2007
|
$34.19
|
2,100
|
|||
Valence
|
7/17/2007
|
$34.20
|
1,100
|
|||
Valence
|
7/17/2007
|
$34.21
|
900
|
|||
Valence
|
7/17/2007
|
$34.23
|
2,700
|
|||
Valence
|
7/17/2007
|
$34.24
|
3,100
|
|||
Valence
|
7/17/2007
|
$34.25
|
4,900
|
|||
Valence
|
7/17/2007
|
$34.26
|
2,200
|
|||
Valence
|
7/17/2007
|
$34.27
|
900
|
|||
Valence
|
7/17/2007
|
$34.28
|
18,000
|
|||
Valence
|
7/17/2007
|
$34.29
|
1,200
|
|||
Valence
|
7/17/2007
|
$34.30
|
800
|
|||
Valence
|
7/17/2007
|
$34.31
|
800
|
|||
Valence
|
7/17/2007
|
$34.32
|
25,700
|
|||
Valence
|
7/17/2007
|
$34.42
|
25,000
|
|||
Synoptic
|
7/18/2007
|
$33.70
|
105
|
|||
Synoptic
|
7/18/2007
|
$33.87
|
400
|
|||
Synoptic
|
7/18/2007
|
$34.03
|
75
|
|||
Valence
|
7/18/2007
|
$33.91
|
139,000
|
|||
Synoptic
|
7/19/2007
|
$33.93
|
(267)
|
|||
Synoptic
|
7/19/2007
|
$33.94
|
(12)
|
|||
Synoptic
|
7/19/2007
|
$33.97
|
54
|
|||
Synoptic
|
7/19/2007
|
$33.99
|
133
|
|||
Synoptic
|
7/19/2007
|
$34.00
|
22
|
|||
Synoptic
|
7/19/2007
|
$34.04
|
(546)
|
|||
Synoptic
|
7/19/2007
|
$34.04
|
481
|
|||
Synoptic
|
7/19/2007
|
$34.07
|
19
|
|||
Synoptic
|
7/19/2007
|
$34.19
|
(300)
|
|||
Synoptic
|
7/19/2007
|
$34.19
|
430
|
|||
Valence
|
7/19/2007
|
$33.85
|
50,000
|
|||
Valence
|
7/19/2007
|
$34.03
|
25,000
|
|||
Valence
|
7/19/2007
|
$34.17
|
1,700
|
|||
Composite
|
7/20/2007
|
$33.66
|
75,000
|
|||
Synoptic
|
7/20/2007
|
$33.59
|
100
|
|||
Synoptic
|
7/20/2007
|
$33.61
|
(19)
|
|||
Synoptic
|
7/20/2007
|
$33.66
|
32
|
|||
Synoptic
|
7/20/2007
|
$33.69
|
511
|
|||
Synoptic
|
7/20/2007
|
$33.70
|